(Q36409465)

English

Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

1 reference

Europe PubMed Central

Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK. (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

methicillin-resistant Staphylococcus aureus

0 references

Staphylococcus aureus

object named as

Staphylococcus aureus

1 reference

based on heuristic

inferred from title

author name string

Curtis G Gemmell

1

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

David I Edwards

2

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

Adam P Fraise

3

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

F Kate Gould

4

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

Geoff L Ridgway

5

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

Rod E Warren

6

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

Joint Working Party of the British Society for Joint Working Party of the British Society for Antimicrobial Chemotherapy, Hospital Infection Society and Infection Control Nurses Association

7

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

language of work or name

0 references

publication date

28 February 2006

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

number of pages

20

1 reference

based on heuristic

inferred from page(s)

Journal of Antimicrobial Chemotherapy

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

57

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

589-608

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

Community-acquired methicillin-resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Methicillin-resistant Staphylococcus aureus bacteraemia diagnosed at hospital admission: distinguishing between community-acquired versus healthcare-associated strains

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Spread of methicillin-resistant Staphylococcus aureus (MRSA) among household contacts of individuals with nosocomially acquired MRSA.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Prevalence of and risk factors for colonization with methicillin-resistant Staphylococcus aureus at the time of hospital admission

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Genome and virulence determinants of high virulence community-acquired MRSA

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Community-acquired methicillin-resistant Staphylococcus aureus: an emerging pathogen

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus musculoskeletal infections in children

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Genesis of methicillin-resistant Staphylococcus aureus (MRSA), how treatment of MRSA infections has selected for vancomycin-resistant Enterococcus faecium, and the importance of antibiotic management and infection control

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Understanding and controlling methicillin-resistant Staphylococcus aureus infections

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Influences of type and duration of antimicrobial prophylaxis on an outbreak of methicillin-resistant Staphylococcus aureus and on the incidence of wound infection

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Reduction in the incidence of methicillin-resistant Staphylococcus aureus and ceftazidime-resistant Klebsiella pneumoniae following changes in a hospital antibiotic formulary

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Rotation and restricted use of antibiotics in a medical intensive care unit. Impact on the incidence of ventilator-associated pneumonia caused by antibiotic-resistant gram-negative bacteria.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Rational use of antibiotics in the intensive care unit: impact on microbial resistance and costs.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Decreased antimicrobial resistance after changes in antibiotic use.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Risk factors for methicillin-resistant Staphylococcus aureus (MRSA) infection in a Japanese geriatric hospital.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Methicillin-resistant Staphylococcus aureus incidence and outcome in patients with neck of femur fractures

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Relationship between spread of methicillin-resistant Staphylococcus aureus and antimicrobial use in a French university hospital.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Methicillin-resistant Staphylococcus aureus in a teaching hospital: investigation of nosocomial transmission using a matched case-control study

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Parallel analysis of individual and aggregated data on antibiotic exposure and resistance in gram-negative bacilli

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

The Nottingham Staphylococcus aureus population study: prevalence of MRSA among the elderly in a university hospital

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Epidemiology of hospital-acquired infections in cirrhotic patients: effect of carriage of methicillin-resistant Staphylococcus aureus and influence of previous antibiotic therapy and norfloxacin prophylaxis

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Is methicillin-resistant Staphylococcus aureus more contagious than methicillin-susceptible S. aureus in a surgical intensive care unit?

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Decline of the hospital Staphylococcus? Incidence of multiresistant Staph. aureus in three Birmingham hospitals

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Comparison of Tn1546-like elements in vancomycin-resistant Staphylococcus aureus isolates from Michigan and Pennsylvania

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Increasing resistance to vancomycin and other glycopeptides in Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to glycopeptides (GISA) in 63 French general hospitals

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Low prevalence of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in Belgian hospitals

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Guidelines for the laboratory diagnosis and susceptibility testing of methicillin-resistant Staphylococcus aureus (MRSA).

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Accessory gene regulator group II polymorphism in methicillin-resistant Staphylococcus aureus is predictive of failure of vancomycin therapy

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

A new UK strain of epidemic methicillin-resistant Staphylococcus aureus (EMRSA-17) resistant to multiple antibiotics

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Characterisation of methicillin-resistant Staphylococcus aureus with reduced susceptibility to teicoplanin in Eastern France

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Treatment of methicillin-resistant staphylococcus aureus infections with quinupristin-dalfopristin in patients intolerant of or failing prior therapy. For the Synercid Emergency-Use Study Group.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Clinical experience with quinupristin-dalfopristin as rescue treatment of critically ill patients infected with methicillin-resistant staphylococci

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Continuous versus intermittent infusion of vancomycin in severe Staphylococcal infections: prospective multicenter randomized study

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Costs and outcomes among hemodialysis-dependent patients with methicillin-resistant or methicillin-susceptible Staphylococcus aureus bacteremia

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Outcome and attributable mortality in critically Ill patients with bacteremia involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Impact of methicillin resistance on the outcome of patients with bacteremia caused by Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Is Methicillin-Resistant Staphylococcus aureus More Virulent than Methicillin-Susceptible S. aureus? A Comparative Cohort Study of British Patients with Nosocomial Infection and Bacteremia

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Higher overall nosocomial infection rate because of increased attack rate of methicillin-resistant Staphylococcus aureus.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Outcome of inappropriate initial antimicrobial treatment in patients with methicillin-resistant Staphylococcus aureus bacteraemia

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Bacteremic pneumonia due to Staphylococcus aureus: A comparison of disease caused by methicillin-resistant and methicillin-susceptible organisms

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Staphylococcus aureus bacteremia: predictors of 30-day mortality in a large cohort

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Treatment and outcome of Staphylococcus aureus bacteremia: a prospective study of 278 cases

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Risk factors for hematogenous complications of intravascular catheter-associated Staphylococcus aureus bacteremia

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Staphylococcus aureus bacteremia: compliance with standard treatment, long-term outcome and predictors of relapse

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Dominance of EMRSA-15 and -16 among MRSA causing nosocomial bacteraemia in the UK: analysis of isolates from the European Antimicrobial Resistance Surveillance System (EARSS).

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Subtyping of methicillin-resistant Staphylococcus aureus isolates from the North-West of England: a comparison of standardised pulsed-field gel electrophoresis with bacteriophage typing including an inter-laboratory reproducibility study

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Molecular characterisation of the dominant UK methicillin-resistant Staphylococcus aureus strains, EMRSA-15 and EMRSA-16.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

National guidelines for the judicious use of glycopeptides in Belgium.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Once-daily versus twice-daily intravenous administration of vancomycin for infections in hospitalized patients

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Failure of treatment with teicoplanin at 6 milligrams/kilogram/day in patients with Staphylococcus aureus intravascular infection. The Infectious Diseases Consortium of Oregon

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

The use and therapeutic drug monitoring of teicoplanin in the UK.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Treatment of endocarditis with teicoplanin: a retrospective analysis of 104 cases

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Linezolid versus teicoplanin in the treatment of Gram-positive infections in the critically ill: a randomized, double-blind, multicentre study.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Vancomycin therapeutic drug monitoring: is there a consensus view? The results of a UK National External Quality Assessment Scheme (UK NEQAS) for Antibiotic Assays questionnaire

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Vancomycin administration and monitoring reappraisal

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Vancomycin toxicity: a prospective study

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Special considerations for monitoring vancomycin concentrations in pediatric patients

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Prediction Model to Identify Patients WithStaphylococcus aureusBacteremia at Risk for Methicillin Resistance

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Use of long-acting tetracyclines for methicillin-resistant Staphylococcus aureus infections: case series and review of the literature

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Letter: In-vitro minocycline activity against tetracycline-resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Minocycline sensitivity related to the phage type of multiply resistant staphylococci

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Treatment of bone and soft tissue infections with teicoplanin.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

The efficacy and safety of linezolid as treatment for Staphylococcus aureus infections in compassionate use patients who are intolerant of, or who have failed to respond to, vancomycin

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Linezolid compared with teicoplanin for the treatment of suspected or proven Gram-positive infections

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Treating foot infections in diabetic patients: a randomized, multicenter, open-label trial of linezolid versus ampicillin-sulbactam/amoxicillin-clavulanate

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Comparison of length of hospital stay for patients with known or suspected methicillin-resistant Staphylococcus species infections treated with linezolid or vancomycin: a randomized, multicenter trial

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Impact of methicillin-resistant Staphylococcus aureus infections on key health economic outcomes: does reducing the length of hospital stay matter?

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Linezolid eradicates MRSA better than vancomycin from surgical-site infections

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Quinupristin-dalfopristin and linezolid: evidence and opinion

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Tolerability, pharmacokinetics, and serum bactericidal activity of intravenous dalbavancin in healthy volunteers

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Glycopeptide antibiotics: from conventional molecules to new derivatives

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Glycopeptides in clinical development: pharmacological profile and clinical perspectives.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

The independent evolution of resistance to ciprofloxacin, rifampicin, and fusidic acid in methicillin-resistant Staphylococcus aureus in Australian teaching hospitals (1990-1995). Australian Group for Antimicrobial Resistance (AGAR).

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

World-wide antibiotic resistance in methicillin-resistant Staphylococcus aureus.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Attempts to eradicate methicillin-resistant Staphylococcus aureus colonization with the use of trimethoprim-sulfamethoxazole, rifampin, and bacitracin

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Randomized double-blinded trial of rifampin with either novobiocin or trimethoprim-sulfamethoxazole against methicillin-resistant Staphylococcus aureus colonization: prevention of antimicrobial resistance and effect of host factors on outcome

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Preventing Staphylococcus aureus infection in the renal unit

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Surgical site infections in orthopedic surgery: the effect of mupirocin nasal ointment in a double-blind, randomized, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Mupirocin - Are we in danger of losing it?

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Transposition of gentamicin resistance to staphylococcal plasmids encoding resistance to cationic agents.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Cloning and expression of Staphylococcus aureus plasmid-mediated quaternary ammonium resistance in Escherichia coli

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Resistance to antiseptics in methicillin and gentamicin resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Transferable resistance to triclosan in MRSA

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Double-blind, placebo-controlled study of oxacillin combined with rifampin in the treatment of staphylococcal infections

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Oral fusidic acid fails to eradicate methicillin-resistant Staphylococcus aureus colonization and results in emergence of fusidic acid-resistant strains

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Eradication of colonization by methicillin-resistant Staphylococcus aureus by using oral minocycline-rifampin and topical mupirocin

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Efficacy of vancomycin plus rifampin in experimental aortic-valve endocarditis due to methicillin-resistant Staphylococcus aureus: in vitro-in vivo correlations

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Treatment of experimental foreign body infection caused by methicillin-resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Fusidic acid alone or in combination with vancomycin for therapy of experimental endocarditis due to methicillin-resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Trimethoprim-sulfamethoxazole compared with vancomycin for the treatment of Staphylococcus aureus infection

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Potential clindamycin resistance in clindamycin-susceptible, erythromycin-resistant Staphylococcus aureus: report of a clinical failure

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Clindamycin treatment of methicillin-resistant Staphylococcus aureus infections in children

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Relationship between molecular epidemiology and antibiotic susceptibility of methicillin-resistant Staphylococcus aureus (MRSA) in a French teaching hospital

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

The impact of MRSA on vascular surgery

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Methicillin-resistant Staphylococcus aureus infections in vascular surgery: increasing prevalence

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

A prospective audit of complex wound and graft infections in Great Britain and Ireland: the emergence of MRSA.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Experimental treatment of vascular graft infection due to Staphylococcus epidermidis by in situ replacement with a rifampin-bonded polyester graft.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Limitations in the use of rifampicin-gelatin grafts against virulent organisms

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Guidelines for the management of intravascular catheter-related infections

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Ciprofloxacin for methicillin-resistant Staphylococcus aureus infections

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Treatment of bone and joint infection with teicoplanin: a retrospective analysis of 50 cases

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Methicillin-resistant Staphylococcus aureus in Dublin 1971-84.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Experience with outpatient intravenous teicoplanin therapy for chronic osteomyelitis

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Vancomycin concentrations in infected and noninfected human bone

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Successful therapy of experimental chronic foreign-body infection due to methicillin-resistant Staphylococcus aureus by antimicrobial combinations

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Comparative efficacies of ciprofloxacin, pefloxacin, and vancomycin in combination with rifampin in a rat model of methicillin-resistant Staphylococcus aureus chronic osteomyelitis

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Hematologic effects of linezolid: summary of clinical experience

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Linezolid for the treatment of multidrug-resistant, gram-positive infections: experience from a compassionate-use program

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Linezolid in the treatment of Gram-positive prosthetic joint infections

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Oral treatment of Staphylococcus spp. infected orthopaedic implants with fusidic acid or ofloxacin in combination with rifampicin

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Risk factors and costs associated with methicillin-resistant Staphylococcus aureus bloodstream infections

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Emergence of methicillin resistant Staphylococcus aureus (MRSA) bacteraemia among children in England and Wales, 1990-2001

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Re-emergence of methicillin-resistant Staphylococcus aureus causing severe infection

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Bacteremia due to methicillin-resistant Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Short-course therapy for right-side endocarditis due to Staphylococcus aureus in drug abusers: cloxacillin versus glycopeptides in combination with gentamicin.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Clinical evaluation of teicoplanin for therapy of severe infections caused by gram-positive bacteria

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Randomized study of vancomycin versus teicoplanin for the treatment of gram-positive bacterial infections in immunocompromised hosts

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Epidemiological and microbiological characterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, United States, 1997-2001.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

The VISA/GISA problem: therapeutic implications

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Quinupristin-dalfopristin resistance in gram-positive bacteria: mechanism of resistance and epidemiology

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Linezolid resistance in Staphylococcus aureus: characterization and stability of resistant phenotype

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Linezolid resistance in sequential Staphylococcus aureus isolates associated with a T2500A mutation in the 23S rRNA gene and loss of a single copy of rRNA.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Daptomycin-resistant, methicillin-resistant Staphylococcus aureus bacteremia.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Guidelines for the antibiotic treatment of endocarditis in adults: report of the Working Party of the British Society for Antimicrobial Chemotherapy.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Therapy of Staphylococcus aureus Bacteremia Associated with a Removable Focus of Infection

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Cost-effectiveness of transesophageal echocardiography to determine the duration of therapy for intravascular catheter-associated Staphylococcus aureus bacteremia

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Role of echocardiography in evaluation of patients with Staphylococcus aureus bacteremia: experience in 103 patients

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Methicillin resistant Staphylococcus aureus (MRSA) infection in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized, double-blind, multicenter study

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Continuation of a randomized, double-blind, multicenter study of linezolid versus vancomycin in the treatment of patients with nosocomial pneumonia

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Clinical cure and survival in Gram-positive ventilator-associated pneumonia: retrospective analysis of two double-blind studies comparing linezolid with vancomycin

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Linezolid for the treatment of children with bacteremia or nosocomial pneumonia caused by resistant Gram-positive bacterial pathogens

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Treatment of gram-positive nosocomial pneumonia. Prospective randomized comparison of quinupristin/dalfopristin versus vancomycin. Nosocomial Pneumonia Group.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Intraocular penetration of the antibiotic fucidin

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Aqueous and vitreous penetration of linezolid (Zyvox) after oral administration

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Methicillin-resistant Staphylococcus aureus and methicillin-resistant coagulase-negative Staphylococcus ocular surface infection efficacy of chloramphenicol eye drops

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

A twelve-year review of central nervous system bacterial abscesses; presentation and aetiology

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Pyrimethamine-clindamycin vs. pyrimethamine-sulfadiazine as acute and long-term therapy for toxoplasmic encephalitis in patients with AIDS.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Effect of Naseptin cream prophylaxis on staphylococcal infection in adult surgical wards and infant nurseries

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

A randomized, controlled trial of tea tree topical preparations versus a standard topical regimen for the clearance of MRSA colonization

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Elimination of nasal carriage of methicillin-resistant Staphylococcus aureus with mupirocin during a hospital outbreak.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Mupirocin-based decolonization of Staphylococcus aureus carriers in residents of 2 long-term care facilities: a randomized, double-blind, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Attempts to eradicate methicillin-resistant Staphylococcus aureus from a long-term-care facility with the use of mupirocin ointment

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Duration of colonization by methicillin-resistant Staphylococcus aureus after hospital discharge and risk factors for prolonged carriage

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Mupirocin-resistant, methicillin-resistant Staphylococcus aureus: does mupirocin remain effective?

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Genetic analysis of methicillin-resistant Staphylococcus aureus expressing high- and low-level mupirocin resistance

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Topical mupirocin for eradication of MRSA colonization with mupirocin-resistant strains

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Effect of vancomycin therapy for osteomyelitis on colonization by methicillin-resistant Staphylococcus aureus: lack of emergence of glycopeptide resistance

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Enteral vancomycin to control methicillin-resistant Staphylococcus aureus outbreak in mechanically ventilated patients

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Decolonization of methicillin-resistant Staphylococcus aureus using oral vancomycin and topical mupirocin

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Effectiveness and safety of enteral vancomycin to control endemicity of methicillin-resistant Staphylococcus aureus in a medical/surgical intensive care unit

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Effects of antibiotics on nosocomial epidemiology of vancomycin-resistant enterococci

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

The association between antecedent vancomycin treatment and hospital-acquired vancomycin-resistant enterococci: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Antecedent treatment with different antibiotic agents as a risk factor for vancomycin-resistant Enterococcus

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Prediction rules to identify patients with methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci upon hospital admission

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Methicillin-resistant Staphylococcus aureus and methicillin-resistant coagulase-negative staphylococci from conjunctivas of preoperative patients

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Use of perioperative mupirocin to prevent methicillin-resistant Staphylococcus aureus (MRSA) orthopaedic surgical site infections

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Prevalence of methicillin-resistant Staphylococcus aureus nasal carriage among patients with femoral neck fractures: implication for antibiotic prophylaxis

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

A clinical trial of mupirocin in the eradication of methicillin-resistant Staphylococcus aureus nasal carriage in a digestive disease unit

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Single-dose peroperative antibiotic prophylaxis in gastrointestinal surgery

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Prophylactic systemic antibiotics in colorectal surgery

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Emergence, spread, and characterization of phage variants of epidemic methicillin-resistant Staphylococcus aureus 16 in England and Wales

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Emergence and Spread of Gentamicin-Susceptible Strains of Methicillin-Resistant Staphylococcus aureus in Belgian Hospitals

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Why monitor peak vancomycin concentrations?

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Excretion of ciprofloxacin in sweat and multiresistant Staphylococcus epidermidis

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKL017

21 January 2018

Identifiers

10.1093/JAC/DKL017

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36409465&oldid=1773669134"